10890619|t|Refractory delirium tremens treated with propofol: a case series.
10890619|a|Delirium tremens, the most serious manifestation of alcohol withdrawal, occurs in approximately 5% of hospitalized alcoholics and has a mortality rate approaching 15%. Patients with delirium tremens are usually treated in an intensive care unit in which benzodiazepines form the cornerstone of therapy. In this report, we describe four patients who proved refractory to high doses of benzodiazepines and were successfully treated with a propofol infusion.
10890619	0	27	Refractory delirium tremens	Disease	MESH:D000430
10890619	41	49	propofol	Chemical	MESH:D015742
10890619	66	82	Delirium tremens	Disease	MESH:D000430
10890619	118	125	alcohol	Chemical	MESH:D000438
10890619	234	242	Patients	Species	9606
10890619	248	264	delirium tremens	Disease	MESH:D000430
10890619	320	335	benzodiazepines	Chemical	MESH:D001569
10890619	402	410	patients	Species	9606
10890619	450	465	benzodiazepines	Chemical	MESH:D001569
10890619	503	511	propofol	Chemical	MESH:D015742
10890619	Negative_Correlation	MESH:D001569	MESH:D000430
10890619	Negative_Correlation	MESH:D015742	MESH:D000430
10890619	Negative_Correlation	MESH:D000438	MESH:D000430

